Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 6/20 | 0.49 |
| ▸ | GRIK2 | Q13002 | 6/20 | 0.49 |
| ▸ | HTR2A | P28223 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | PAM | P19021 | 1/20 | 0.42 |
| ▸ | CTSC | P53634 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.40 |
| ▸ | MIF | P14174 | 1/20 | 0.40 |
| ▸ | NOS2 | P35228 | 1/20 | 0.40 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.40 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16147766 | 1.00 | GRIK1 (0.49) | GRIK1GRIK2HTR2AKMT2APAM | |
| SCHEMBL16147768 | 1.00 | GRIK1 (0.49) | GRIK1GRIK2HTR2AKMT2APAM | |
| SCHEMBL1859895 | 0.86 | ALDH1A1 (0.50) | GRIK1GRIK2HTR2AKMT2ANOS2 | |
| SCHEMBL6553397 | 0.84 | GRIK1 (0.50) | GRIK1GRIK2HTR2AKMT2APAM | |
| SCHEMBL6553405 | 0.84 | GRIK1 (0.50) | GRIK1GRIK2HTR2AKMT2APAM | |
| SCHEMBL7005960 | 0.83 | GRIK1 (0.63) | GRIK1GRIK2HTR2APAM | |
| SCHEMBL12123422 | 0.80 | HTR2A (0.50) | GRIK1GRIK2HTR2AKMT2APAM | |
| SCHEMBL5835825 | 0.79 | GRIK1 (0.50) | GRIK1GRIK2HTR2AKMT2APAM | |
| SCHEMBL27947171 | 0.79 | HTR2A (0.53) | GRIK1GRIK2HTR2AKMT2APAM | |
| SCHEMBL5835829 | 0.79 | GRIK1 (0.50) | GRIK1GRIK2HTR2AKMT2APAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1347978-A1 | NOVEL SUBSTITUTED IMIDAZOTRIAZINONES AS PDE II-INHIBITORS | Bayer Aktiengesellschaft (DE) | 2003-10-01 | — | — | EP | disclosed |
| WO-2002050078-A1 | NOVEL SUBSTITUTED IMIDAZOTRIAZINONES AS PDE II-INHIBITORS | BAYER AKTIENGESELLSCHAFT (DE) | 2002-06-27 | — | — | WO | disclosed |